Followers

August 17, 2024

Aurobindo Pharma's Eugia Unit-3 gets warning letter from USFDA, shares fall

​The Unit-3 site under USFDA scanner belongs to the Eugia Pharma Specialities - that houses company's injectable business. Eugia's Unit-3 is a critical to the Hyderabad-based drugmaker's future growth. Out of the 54 abbreviated new drug applications (ANDAs) filed by Eugia under review before USFDA, 29 are filed from the Unit-3.

from Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/c7LPjo3

No comments:

Post a Comment